No data available
Kymab is a biopharmaceutical company using a proprietary transgenic antibody platform, Kymouse, to discover and develop fully human monoclonal antibody drugs. The technology used to design the Kymouse strains originated from the Wellcome Trust Sanger Institute in Cambridge, UK. Kymouse™ has been designed to maximise the diversity of human antibodies produced in response to immunisation. Selecting from a broad diversity of fully human antibodies assures the highest probability of finding that rare drug candidate with best-in-class characteristics.
No data available
Latham & Watkins are a global international law firm offering life sciences and healthcare industry leaders deep sector knowledge, legal expertise, and commercial and government insights. Latham’s cross-disciplinary healthcare and life sciences team delivers insightful, practical guidance and sophisticated representation to a full spectrum of companies across the globe, on every type of transaction or dispute a company may face. Many of us hold advanced scientific degrees and have served in senior positions as government regulators, C-Suite executives in leading healthcare and life sciences companies, as well as serving as primary outside counsel for key industry associations.
Watch our Member Showcase Video https://bit.ly/3rsZDkp
Watch our Member Showcase Video https://bit.ly/3rsZDkp
No data available
LBIC provides laboratories, offices and technical support to over 40 life science product and diagnostic companies, CROs, medical device companies and associated service providers. Our Virtual Client package is a risk-free option for companies looking to establish a presence in London without incurring the expense of setting up an office, or employing staff on the ground. LBIC is located 10 minutes' walk from St Pancras International, Eurostar and the site of the Francis Crick Institute. LBIC is owned by the Royal Veterinary College (RVC), the UK’s largest and longest-established veterinary institution and a leading centre for comparative and translational medicine. Watch our Member Showcase Video https://bit.ly/33RExnm
With over 25 years' of expertise in the IVD Industry, we are dedicated to helping businesses in launching new and innovative diagnostic products.
Founded in 2023, Lehane Consulting Ltd offers unparalleled medical diagnostic knowledge to companies developing diagnostic tools that enhance and innovate healthcare. With 70% of NHS clinical decisions relying on Laboratory or Point of Care tests, such results are pivotal for accurate diagnoses, commencing effective treatments, and comprehensive patient management. Navigating the market introduction of diagnostic tests is complex; therefore, Lehane Consulting delivers essential advice, guidance and support for product development, market analysis, clinical study design, and medical communications throughout your product's lifecycle.
Contact us at Lucy@lehaneconsulting.co.uk, visit our website at www.lehaneconsulting.co.uk, or follow us on Twitter @LehaneConsult.
Founded in 2023, Lehane Consulting Ltd offers unparalleled medical diagnostic knowledge to companies developing diagnostic tools that enhance and innovate healthcare. With 70% of NHS clinical decisions relying on Laboratory or Point of Care tests, such results are pivotal for accurate diagnoses, commencing effective treatments, and comprehensive patient management. Navigating the market introduction of diagnostic tests is complex; therefore, Lehane Consulting delivers essential advice, guidance and support for product development, market analysis, clinical study design, and medical communications throughout your product's lifecycle.
Contact us at Lucy@lehaneconsulting.co.uk, visit our website at www.lehaneconsulting.co.uk, or follow us on Twitter @LehaneConsult.
LEX Diagnostics is a spin out from TTP plc, a leading technology development company in the life science and medical device sector. The origins of the LEX technology lie in an internal R&D project to reduce the time it takes to get a result from a PCR test. We formed a company when it became clear the solution also reduced the cost and size of any diagnostic device using it.
LifeArc is the new name for MRC Technology, a medical research charity with a 25 year legacy of helping scientists and organisations turn their research into treatments and diagnostics for patients. . The new name reflects the charity’s purpose: to be the arc or bridge between research and improving patients’ lives.. . LifeArc is pioneering new ways to turn great science into greater patient impact. It brings together a network of partners to tackle specific diseases and directly funds academic and early stage research. . . So far, LifeArc’s work has helped to develop four drugs (Keytruda®, Actemra®, Tysabri® and Entyvio®) and a test for antimicrobial resistance. . . https://www.lifearc.org Twitter @lifearc1.
LifeSciences BC is a not-for-profit, non-government industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, and advocacy and promotion of our world-class science and industry. Life science sectors, from biopharmaceuticals and medical technology to digital health and medical devices, are integrated into our organisation and our activities, ensuring that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary and coordinated fashion. Throughout the year, LifeSciences BC undertakes numerous programmes and projects in support of these sectors.